Literature DB >> 15927783

Anxiety sensitivity: stability in prospective research.

Nicholas Maltby1, Michael F Mayers, George J Allen, David F Tolin.   

Abstract

Several recent panic prevention studies suggest that anxiety sensitivity, as measured by the Anxiety Sensitivity Index (ASI), may not be stable under certain conditions. In two investigations [Behav. Ther. 32 (2001) 725; Disertation Abstr. Int. 62 (2001) 4226], wait-list or no-treatment conditions produced ASI scores at follow-up that were significantly reduced from baseline and comparable to those of the intervention groups. Although design characteristics could not rule out regression to the mean as the source of these changes, the authors suggested that these findings were most likely due to nonspecific factors such as reassurance, support, or the expectation of receiving subsequent treatment. The present study sought to replicate and extend these findings by analyzing the contribution of a detailed diagnostic assessment on ASI scores. Two cohorts of high-risk-for-panic participants scoring in the high range of the ASI were studied. Cohort 1 received a detailed diagnostic assessment and then either no-treatment or one of two anxiety sensitivity reduction interventions. Cohort 2 did not receive a detailed diagnostic assessment or an intervention. Both groups were followed up 2 weeks after baseline assessment. Results were consistent with the hypothesis that ASI total and subscale scores are unstable in the presence of structured interviews. Participants receiving a diagnostic assessment produced ASI scores that were significantly lower than at baseline with the average ASI score dropping from the high to the average range. ASI scores of participants not receiving a diagnostic assessment, however, were unchanged from baseline.

Entities:  

Mesh:

Year:  2005        PMID: 15927783     DOI: 10.1016/j.janxdis.2004.08.003

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  7 in total

1.  The Efficacy of Vigorous-Intensity Exercise as an Aid to Smoking Cessation in Adults With High Anxiety Sensitivity: A Randomized Controlled Trial.

Authors:  Jasper A J Smits; Michael J Zvolensky; Michelle L Davis; David Rosenfield; Bess H Marcus; Timothy S Church; Mark B Powers; Georita M Frierson; Michael W Otto; Lindsey B Hopkins; Richard A Brown; Scarlett O Baird
Journal:  Psychosom Med       Date:  2016-04       Impact factor: 4.312

Review 2.  Community-based prevention programs for anxiety and depression in youth: a systematic review.

Authors:  Helen Christensen; Emma Pallister; Stephanie Smale; Ian B Hickie; Alison L Calear
Journal:  J Prim Prev       Date:  2010-06

3.  Exercise Self-Efficacy Moderates the Relation between Anxiety Sensitivity and Body Mass Index and Exercise Tolerance in Treatment-Seeking Smokers.

Authors:  Samantha G Farris; Michelle L Davis; David Rosenfield; Brooke Y Kauffman; Scarlett O Baird; Mark B Powers; Michael W Otto; Bess H Marcus; Timothy S Church; Jasper A J Smits; Michael J Zvolensky
Journal:  Ment Health Phys Act       Date:  2016-05-10

4.  Psychometrics of social cognitive measures for psychosis treatment research.

Authors:  Charlie A Davidson; Rebecca Lesser; Lori T Parente; Joanna M Fiszdon
Journal:  Schizophr Res       Date:  2017-06-23       Impact factor: 4.939

5.  Contextual Influences on Distress Intolerance: Priming Effects on Behavioral Persistence.

Authors:  Kristin L Szuhany; Michael W Otto
Journal:  Cognit Ther Res       Date:  2015-08

6.  One-Month Stability of Cyberball Post-Exclusion Ostracism Distress in Adolescents.

Authors:  Charlie A Davidson; Cynthia J Willner; Stefon J R van Noordt; Barbara C Banz; Jia Wu; Joshua G Kenney; Jason K Johannesen; Michael J Crowley
Journal:  J Psychopathol Behav Assess       Date:  2019-02-11

7.  Assessment of Magnitude and Associated Factors of Emergence Delirium in the Post Anesthesia Care Unit at Tikur Anbesa Specialized Hospital, Ethiopia.

Authors:  Solomon Assefa; Wosenyeleh A Sahile
Journal:  Ethiop J Health Sci       Date:  2019-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.